Search Results - "Lueke, F"

Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab by Reuthner, K, Aubele, P, Menhart, K, Rath, P, Harrer, D C, Herr, W, Hahn, J, Vogelhuber, M, Heudobler, D, Lueke, F, Reichle, A, Grube, M

“…Targeted chemotherapy and immune checkpoint inhibitors (ICPi) have expanded the spectrum of therapies for patients with relapsed/refractory (r/r) Hodgkin's…”
Get full text

LBA35 BNT211-01: Interim results from a repeat dose escalation study of CLDN6 CAR-T cells manufactured with an automated process ± a CLDN6-encoding CAR-T cell-amplifying RNA Vaccine (CARVac) by Mackensen, A., Haanen, J.B.A.G., Alsdorf, W., Koenecke, C., Wagner-Drouet, E., Borchmann, P., Heudobler, D., Busse, A., Klobuch, S., Kutsch, N., Müller, F., Bokemeyer, C., Desuki, A., Lueke, F., Ho, T., Vemuri, K., Preussner, L., Rengstl, B., Türeci, Ö., Sahin, U.

Get full text

Early clinical trial unit tumor board: a real-world experience in a national cancer network by Weiss, L., Dorman, K., Boukovala, M., Schwinghammer, F., Jordan, P., Fey, T., Hasselmann, K., Subklewe, M., Bücklein, V., Bargou, R., Goebeler, M., Sayehli, C., Spoerl, S., Lüke, F., Heudobler, D., Claus, R., von Luettichau, I., Lorenzen, S., Lange, S., Westphalen, C. B., von Bergwelt-Baildon, M., Heinemann, V., Gießen-Jung, C.

“…Purpose Early clinical trials are the first step into clinical therapies for new drugs. Within the six Bavarian university-based hospitals (Augsburg, Erlangen,…”
Get full text

Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab by Reuthner, K, Aubele, P, Menhart, K, Rath, P, Harrer, D C, Herr, W, Hahn, J, Vogelhuber, M, Heudobler, D, Lueke, F, Reichle, A, Grube, M

“…Targeted chemotherapy and immune checkpoint inhibitors (ICPi) have expanded the spectrum of therapies for patients with relapsed/refractory (r/r) Hodgkin's…”
Get full text

Plasma hydroxyproline in chronic renal failure (author's transl) by Heidbreder, E, Lüke, F, Heidland, A

“…The plasma concentration of hydroxyproline fractions were determined in 50 adult patients with renal insufficiency and 19 patients receiving maintenance…”
Get more information

A time-resolved fluoroimmunoassay for the determination of prostaglandin F2 alpha by Lüke, F J, Schlegel, W

“…We describe a solid-phase immunoassay based on fluorescence detection for Prostaglandin F2 alpha (PGF2 alpha). Europium was used as the fluorescence marker…”
Get more information

The gastrointestinal manifestations of amyloidosis by Neef, B, Höring, E, Lüke, F, von Gaisberg, U

Get more information

Chronic copper poisoning and copper retention in the liver of sheep of different strains by Lüke, F, Wiemann, H

Get more information

Bone collagen metabolism in uremia--studies of plasma hydroxyproline level in chronic, non-dialyzed kidney disease by Heidbreder, E, Lüke, F, Heidland, A

Get more information